Loading
CI
Cynosure Inc Stock: price and insider trades · United States
Cynosure Inc: what insiders have been doing
Every trade that managers of Cynosure Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Cynosure Inc in twelve months, the latest record being from 12 February 2016.
Elsewhere in the same market, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
3 ops. · all time
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
RevenueUS$375.3M
Gross profitUS$221M59% margin
Net incomeUS$12.3M3.3% margin
Last declaration on 12 February 2016
Declarations12 total
5,169 sharesClass A Common StockSEC:0001209191-16-098111:0
2,570 sharesClass A Common StockSEC:0001209191-16-098111:1
11,089 sharesClass A Common StockSEC:0001209191-16-098110:0
5,505 sharesClass A Common StockSEC:0001209191-16-098110:1
5,169 sharesClass A Common StockSEC:0001209191-16-098112:0
2,660 sharesClass A Common StockSEC:0001209191-16-098112:1
100 sharesClass A Common StockSEC:0001209191-16-088468:0
100 sharesClass A Common StockSEC:0001209191-16-088468:1
200 sharesClass A Common StockSEC:0001209191-16-088471:0
200 sharesClass A Common StockSEC:0001209191-16-088471:1
200 sharesClass A Common StockSEC:0001209191-16-088472:0
200 sharesClass A Common StockSEC:0001209191-16-088472:1
12 of 12 declarations
About Cynosure Inc
Cynosure Inc is a company specializing in aesthetic technologies, providing solutions for skin treatment and non-surgical procedures. It is listed on the NASDAQ under the symbol CYNO.
